Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of 13-valent pneumococcal conjugate vaccine on the incidence of hospitalizations for all-cause pneumonia among children aged less than 5 years in Burkina Faso: An interrupted time-series analysis.
Kaboré L, Ouattara S, Sawadogo F, Gervaix A, Galetto-Lacour A, Karama R, Traoré AT, Méda B, Tall H, Essoh AT, Gessner BD, Moïsi JC. Kaboré L, et al. Int J Infect Dis. 2020 Jul;96:31-38. doi: 10.1016/j.ijid.2020.03.051. Epub 2020 Mar 28. Int J Infect Dis. 2020. PMID: 32234344 Free article.
Assessment of missed opportunities for vaccination (MOV) in Burkina Faso using the World Health Organization's revised MOV strategy: Findings and strategic considerations to improve routine childhood immunization coverage.
Kaboré L, Meda B, Médah I, Shendale S, Nic Lochlainn L, Sanderson C, Ouattara M, Kaboré WMF, Betsem E, Ogbuanu IU. Kaboré L, et al. Among authors: kabore wmf. Vaccine. 2020 Nov 10;38(48):7603-7611. doi: 10.1016/j.vaccine.2020.10.021. Epub 2020 Oct 17. Vaccine. 2020. PMID: 33077298 Free PMC article.
Pneumococcal Carriage in Burkina Faso After 13-Valent Pneumococcal Conjugate Vaccine Introduction: Results From 2 Cross-sectional Population-Based Surveys.
Kaboré L, Adebanjo T, Njanpop-Lafourcade BM, Ouangraoua S, Tarbangdo FT, Meda B, Velusamy S, Bicaba B, Aké F, McGee L, Yaro S, Betsem E, Gervaix A, Gessner BD, Whitney CG, Moïsi JC, Van Beneden CA. Kaboré L, et al. J Infect Dis. 2021 Sep 1;224(12 Suppl 2):S258-S266. doi: 10.1093/infdis/jiab037. J Infect Dis. 2021. PMID: 34469552 Free PMC article.
Impact of Introducing Hepatitis B Birth Dose Vaccines into the Infant Immunization Program in Burkina Faso: Study Protocol for a Stepped Wedge Cluster Randomized Trial (NéoVac Study).
Tall H, Adam P, Tiendrebeogo ASE, Vincent JP, Schaeffer L, von Platen C, Fernandes-Pellerin S, Sawadogo F, Bokoum A, Bouda G, Ouattara S, Ouédraogo I, Herrant M, Boucheron P, Sawadogo A, Betsem E, Essoh A, Kabore L, Ouattara A, Méda N, Hien H, Gosset A, Giles-Vernick T, Boyer S, Kania D, Vray M, Shimakawa Y. Tall H, et al. Among authors: kabore l. Vaccines (Basel). 2021 Jun 1;9(6):583. doi: 10.3390/vaccines9060583. Vaccines (Basel). 2021. PMID: 34206058 Free PMC article.
Missed opportunities for vaccination among children aged 0-23 months visiting health facilities in a southwest State of Nigeria, December 2019.
Fatiregun AA, Lochlainn LN, Kaboré L, Dosumu M, Isere E, Olaoye I, Akanbiemu FA, Olagbuji Y, Onyibe R, Boateng K, Banda R, Braka F. Fatiregun AA, et al. Among authors: kabore l. PLoS One. 2021 Aug 27;16(8):e0252798. doi: 10.1371/journal.pone.0252798. eCollection 2021. PLoS One. 2021. PMID: 34449777 Free PMC article. Clinical Trial.
31 results